Company Data
Salarius Pharmaceuticals
Ticker
SLRX
Current Price
$0.5049 -0.61%
Market Cap
$2.2M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$0.43 - $2.31
Overview
Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.